Health Economics›Colorectal cancer›Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy
Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy
Colorectal cancer · 1 regimen
Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.
Filters
Y-axis
Cost vs Efficacy
No data points — cost or PFS missing for current selection.